AMN
This unit is headed by Inspector rank officer. With this induction, total units under CISF security cover has risen to 351 as on date.
Bharat Biotech International Limited (BBIL), Hyderabad, is an Indian biotechnology company engaged in drug discovery, drug development, and manufacture of vaccines, bio-therapeutics, pharmaceuticals and health care products.
BBIL is one of the first to develop vaccines for viral diseases like Chikungunya and Zika. It also produces vaccines for Japanese Encephalitis. It is the first fully indigenous manufacturers of COVID-19 vaccine called COVAXIN in India.
The biohazard of any accidental or sabotage related leakage of the material has the potential of a widespread disaster.
In the light of the increased threat perception to the biotechnology company situated across the country, BBIL is inherently vulnerable to threats from anti-nationals & saboteurs.
The CISF will provide round-the-clock armed security cover to the Bharat Biotech International Limited, Hyderabad.
The induction ceremony was attended by Bharat Biotech CMD Dr. Krishna Ella and CISF IG Anjana Sinha.
Other officers & personnel of CISF & Bharat Biotech International Ltd were present during the occasion.